Lexicon Pharmaceuticals Inc (LXRX) support and resistance · rev $21.8M
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
This page maps Lexicon Pharmaceuticals Inc (LXRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
LXRX currently screens at market cap $327.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new LXRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the LXRX quote page for the session range and the stock page for the full model.
Not investment advice.